Abstract. Lymph node metastasis is an important clinicopathological feature of papillary thyroid carcinoma (PTC). PTC having clinically apparent lateral node metastasis detectable on preoperative imaging studies (N1b) is known to show a dire prognosis. however, N1b cases include various levels of biological aggressiveness, depending on the size, number, laterality and invasiveness of metastatic nodes. We investigated differences in the prognoses of 621 N1b patients based on these features and compared their prognoses with those of 4297 patients without clinically apparent metastasis (N0) and 125 patients with clinically apparent central node metastasis only (N1a). Disease-free survival (DFS) and cause-specific survival (CSS) of N1b or N1a patients were significantly worse than those of N0 patients, but the prognosis of N1b patients did not differ from that of N1a patients. in the subset of N1b patients, metastatic nodes larger than 3cm, extranodal extension, or 5 or more clinically apparent metastatic nodes independently affected DFs and a combination of the former two features also showed an effect on Css on multivariate analysis. Prognosis of N1b patients who had none of these features did not differ from that of N1a patients. it is therefore suggested that N1b patients having metastasis larger than 3cm, those showing extranodal extension, and those having 5 or more clinically apparent metastasis should regarded as high-risk, and that careful surgical treatment and postoperative follow-up are necessary. . The UICC TNM classification is the most traditional classification system and widely adopted for this purpose [5] . unlike the other classification systems, this system evaluates time-oriented carcinoma progression by upstaging based on T factor (tumor size and extrathyroid extension), N factor (lymph node metastasis), M factor (distant metastasis) and patient age. There are two regional lymph node compartments that are prominent in thyroid carcinoma: the central and lateral compartments. N factor is divided into three categories in the UICC TNM classification [5]; N0, no clinically apparent node metastasis; N1a, clinically apparent central node metastasis; N1b, clinically apparent lateral (or mediastinal) node metastasis, N1b is considered the highest N factor. although PTC can initially metastasize to either compartment with a similar incidence [6], N1b cases are graded higher than N1a cases in the TNM classification and N1b pa-
PAPILLARY thyroid carcinoma (PTC) is the most common malignancy originating from the thyroid. although this disease generally grows slowly, cases demonstrating certain clinicopathological parameters are progressive, have a dire prognosis and are regarded as high-risk. There are various classification systems for thyroid carcinoma that have been established in the united states in order to identify high-risk cases such as aMEs, aGEs and MaCis [1] [2] [3] . in Japan as well, sugitani et al. proposed that PTC patients of any age who demonstrate distant metastasis and patients aged 50 years or older with extrathyroid extension or large lymph node metastasis should be classified as high-risk [4] . The UICC TNM classification is the most traditional classification system and widely adopted for this purpose [5] . unlike the other classification systems, this system evaluates time-oriented carcinoma progression by upstaging based on T factor (tumor size and extrathyroid extension), N factor (lymph node metastasis), M factor (distant metastasis) and patient age.
There are two regional lymph node compartments that are prominent in thyroid carcinoma: the central and lateral compartments. N factor is divided into three categories in the UICC TNM classification [5] ; N0, no clinically apparent node metastasis; N1a, clinically apparent central node metastasis; N1b, clinically apparent lateral (or mediastinal) node metastasis, N1b is considered the highest N factor. although PTC can initially metastasize to either compartment with a similar incidence [6] , N1b cases are graded higher than N1a cases in the TNM classification and N1b pa-tasis only in the central compartment (N1a) were adopted as control groups. Patients with pT4 or M1 were also excluded from these groups.
Postoperative follow-up and evaluation of recurrence scintigraphy using a small amount of radioiodine (3-13 mCi) was performed at our outpatient clinic 1-2 months after total or near total thyroidectomy for 185 N1b patients and none of the patients showed abnormal uptake. Twenty-two patients showing areas of abnormal uptake suggesting metastases in distant organs were regarded as M1 patients and excluded from the series.
We followed patients by annual ultrasonography to screen for any signs of local recurrence. Either chest roentgenography or CT scan was also performed annually. Postoperative follow-up periods averaged 71.9 months (2-163 months). We regarded a patient as showing recurrence when recurrence was apparent on imaging studies.
Statistical analyses
Fishers exact test was adopted for comparing variables. The Kaplan-Meier method and log rank test were also adopted to analyze time-dependent varitients are classified as stage IV regardless of other factors such as tumor size and extrathyroid extension if the patient is 45 years or older. N factor is evaluated by preoperative imaging studies and at present, ultrasonography is the most useful tool for this purpose. We previously demonstrated that lateral node metastasis detectable on ultrasonography much more significantly affected the prognosis of PTC patients than metastasis that is detected on postoperative pathological examination (pN1b) [7] . However, cases classified as N1b demonstrate various severities of node metastasis including differences in size, number and invasiveness of metastases, indicating that the aggressiveness of N1b carcinoma is also varied. in this study, therefore, we performed segmentalized analysis to investigate which factors further indicate a worsened prognosis in N1b patients.
Patients and Methods

Patients
Between 1994 and 2004, 621 patients who showed clinically apparent lateral node metastasis on preoperative ultrasonography and were classified as N1b underwent initial surgical treatment at Kuma hospital. These patients were enrolled in this study. Lymph node metastasis was evaluated on ultrasonography subject to the criteria described previously [8] . in some cases, we performed fine needle aspiration biopsy (FNaB) for nodes suspected of metastasis and measurement of thyroglobulin in wash-out of needles used for FNAB to confirm the diagnosis [9] . Furthermore, we measured the maximal diameter of metastatic nodes, counted the number of metastatic nodes and investigated whether metastatic nodes were located unilaterally or bilaterally on ultrasonography. in this series, we do not discriminate between cystic and solid node metastases. Metastases th at had fused together were measured as a single node. Patients having PTC with massive extrathyroid extension (pT4), metastasis to the mediastinal lymph nodes and distant metastasis at diagnosis (M1) were excluded from our series. Table 1 shows the extent of thyroidectomy and lymph node dissection in 621 N1b patients.
Forty-two hundred and ninety-seven patients who showed no clinically apparent node metastasis (N0) and 125 who showed clinically apparent node metas- Five patients with N1b PTC (0.8%) have died of carcinoma. Fig. 1-b indicates Kaplan-Meier curves of cause-specific survival (CSS) of patients with N1b, N1a, and N0. CSS of N1b or N1a patients was significantly worse (p = 0.0010) than that of N0 patients, but Css of N1b patients did not differ from that of N1a patients.
Prognostic significance of the status of lateral node metastasis in 621 N1b patients
in the subset of 621 N1b patients, we investigated the prognostic significance of size, number, location and extranodal carcinoma extension of metastatic lateral nodes.
seventy patients had lateral node metastasis larger than 3 cm. as shown in Fig 2-a and 2 -b, DFs and Css of these patients were significantly worse (p < ables. Furthermore, Cox regression model was adopted for multivariate analysis. These analyses were performed using StatView-J 5.0. A p value less than 0.05 was regarded as significant.
Results
Prognosis of N1b patients
To date, 84 of 621 N1b patients (13.5%) showed carcinoma recurrence during follow-up. Table 2 indicates the organs to which PTC recurred. We compared disease-free survival (DFs) of these N1b patients with those of N0 or N1a patients ( Fig. 1-a) . N1b or N1a patients showed significantly worse DFS than N0 patients (p < 0.0001), but the DFs of N1b patients did not differ from that of N1a patients. of 410 patients younger than 55 years on univariate analysis. on multivariate analysis, 5 or more metastases was recognized as an independent prognostic factor (Table 7) . We could not perform an appropriate analysis regarding Css for the subset of patients aged 55 years or older, because only 1 patient died of carcinoma. For the subset of patients younger than 55 years, metastasis larger than 3 cm (p = 0.0074) and extranodal extension (p < 0.0001) significantly affected Css on univariate analysis. since no patients having 5 or more metastasis died of carcinoma, multivariate analysis was performed for the remaining three parameters and extranodal extension independently reflect worse Css (Table 8) .
0.0001 and p = 0.0003, respectively) than those having metastasis measuring 3 cm or less. Furthermore, prognosis of patients having metastasis measuring 3 cm or less did not differ from that of N1a patients. Five or more metastatic nodes and metastasis to the bilateral compartments were detected in 117 and 123 patients, respectively. DFs of these patients was significantly worse (p < 0.0001 and p = 0.0006, respectively), but these two parameters did not affect Css of patients (data not shown). Extranodal extension was judged during surgery and twenty-six patients whose metastatic nodes in the lateral compartment extended to the adjacent organs requiring their excision were classified as having extranodal extension, corresponding to nodal ex2 in our previous study [10] . organs to which metastatic nodes extended are summarized in Table 3 . DFs and Css of patients having extranodal extension were significantly worse (p < 0.0001) than those of patients without extranodal extension (Fig.  3-a and 3-b) . Prognosis of patients without extranodal extension did not differ from that of N1a patients.
results of multivariate analysis of DFs and Css of N1b patients are summarized in Tables 4 and 5 . Metastasis larger than 3 cm, 5 or more metastases, and extranodal extension were recognized as independent prognostic factors for DFs. Metastasis larger than 3 cm and extranodal extension independently affected Css of patients.
Difference in prognostic factors between elderly and younger patients
in the next step of the study, we investigated prognostic factors for elderly and younger patients. since the prognoses of elderly and younger patients most clearly differed when the cut off was set at 55 years old [10, 11] , we investigated the prognostic significance of these four parameters for two subsets of patients aged 55 years or older and those younger than 55 years.
in the series of 211 patients aged 55 years or older, metastasis larger than 3 cm (p < 0.0001) and extranodal extension (p = 0.0003) significantly affected DFS of patients on univariate analysis. on multivariate analysis, only metastasis larger than 3 cm independently affected DFs (Table 6 ). in contrast, patients having metastasis larger than 3 cm (p = 0.0084), 5 or more metastases (p < 0.0001) or extranodal extension (p = 0.0014) showed significantly worse DFS in the subset ing to the number of parameters they had. Four hundred and fifty-nine patients were scored as 0, 117 were scored as 1, 42 were scored as 2 and 3 were scored as 3. as shown in Fig. 4 -a, DFs of patients scored 2 or more was significantly worse than that of patients scored 1 (p = 0.0176) and that of patients scored 1 was also worse than that of patients with score 0 (p < 0.0001). Fig.  4 -b shows the Css of patients with scores of 0, 1, and 2 or more. Patients with score 2 or more showed significantly worse CSS than those with score 0 or 1 (p < 0.0001). There was no evidence that the Css of patients with score 1 was worse than that of those with score 0, since none of patients with score 1 died of carcinoma.
Scoring of prognostic factors for CSS and DFS of patients
as indicated in the results of multivariate analysis (Table 4) , three parameters, metastasis larger than 3 cm, 5 or more metastases, and extranodal extension could be regarded as independent prognostic factors with a similar level of contribution. We also investigated whether the prognoses of patients having none, only one or two or more of these parameters differ from one another. Table 9 indicates the relationship among these parameters. Metastasis larger than 3 cm showed a direct relationship with 5 or more metastases and extranodal extension (Tables 9-a and b), although extranodal extension was not related to 5 or more metastasis (data not shown). We scored patients from 0 to 3 accord- more metastases showed worse DFs on multivariate analysis but the DFs of other N1b patients did not differ from that of N1a patients. These findings suggest that, among N1b cases, those having at least one of the three clinicopathological parameters are regarded as high-risk and careful surgical treatment and postoperative follow-up are required. it is notable that metastatic nodes larger than 3 cm and extranodal extension independently affected the Css of patients, while the number of metastases did not, suggesting that the size of the metastatic node impacts Css of patients more intensely than the number of metastases. indeed, sugitani et al. demonstrated that 3 of 4 patients with papillary microcarcinoma who died of carcinoma had lymphadenopathy measuring 4cm or larger in the lateral compartment [12] , which was not discrepant with our findings. another important finding is the relationship between prognostic impact of lymph node status and pa-
Discussion
in this study, we demonstrated that PTC patients with clinically apparent node metastasis in the central and/or lateral compartments showed significantly worse DFs and Css than those without preoperatively detectable node metastasis. in the uiCC TNM classification, cases showing clinically apparent lateral node metastasis (N1b) are graded higher than those with metastasis in the central compartment only (N1a) [5] . however, in our series, DFs or Css of N1b patients did not significantly differ from that of N1a patients. These findings indicate that clinically apparent metastasis has a prognostic impact for PTC patients but upgrading or upstaging of all N1b patients compared to N1a patients is not appropriate.
in the current study, we demonstrated that patients having lateral node metastasis larger than 3cm, those having extranodal extension, or those having 5 or Table 9 . relationships among the status of metastasis showed a worse Css than those without extranodal extension. in the current study examining a subset of N1b patients, prognosis of patients with nodal ex2 in the lateral compartment was significantly worse than that of other patients, but prognosis of nodal ex1 patients did not differ from that of those without extranodal extension (data not shown). since this event (nodal ex2) significantly affected DFs and Css of N1b patients, when surgeons encounter this finding, they should recognize that the patient is more likely to show recurrence and die of carcinoma than other N1b patients.
in this study, we showed that many patients had more than one of the three features, because large lymph node was directly linked to the number of metastasis and to extranodal extension. Furthermore, it was demonstrated that patients having two or more of these features showed worse DFs or Css than those having only one of them. These findings indicate that these three features have a synergetic effect on the worse prognosis of N1b patients. in summary, N1b or N1a cases showed a significantly worse prognosis than N0 patients, and N1b cases should be regarded as high-risk when they show metastasis larger than 3cm, 5 or more metastases, or extranodal extension. N1b cases without any of these three features have a malignant potential and biological aggressiveness similar to N1a cases, if they do not demonstrate other aggressive features such as extrathyroid extension and distant metastasis.
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authors are thankful to Professor Kiyoshi ichihara (Department of Clinical Laboratory sciences, Faculty of health sciences, Yamaguchi university Graduate school of Medicine) for his useful advice especially for statistical analyses. tient age. Large node metastasis but not the number of metastases was an independent prognostic factor of DFs in the subset of patients aged 55 years or older, while only the number of metastases affected DFs of patients younger than 55 years. sugitani et al. demonstrated that number of pathologically confirmed metastases independently affected DFs of patients younger than 50 years and large lymph node predicted worse prognosis (both DFs and Css) of those aged 50 years or older [4] . They also proposed that patients aged 50 years or older having large lymph node, extrathyroidal invasion, or distant metastasis should be regarded as high-risk because of the high incidence of carcinoma-related death in this patient group [4] . We obtained results similar to those of sugitani et al. while using a different approach for DFs. regarding Css, extranodal extension was the strongest prognostic factor for patients aged 55 years or older. however, in our series, the number of patients who died of carcinoma was small at 5 and follow-up period was short (approximately 6 years in average). studies based on series of patients with a longer follow-up are necessary to draw more reliable conclusions.
Extranodal tumor extension has also been studied by a few researchers including us [10, [13] [14] [15] . Yamashita et al. showed that pathologically confirmed extranodal tumor extension was more frequently observed in PTC showing recurrence to distant organs than in control cases without recurrence [15] . We also studied this issue in a series of 1692 PTC patients by dividing extranodal extension into two categories according to the intra-operative findings; nodal ex1 (76 patients), hard metastatic nodes with perinodal growth extending to adjacent organs, which required separation of the nodes from the organs, and nodal ex2 (59 patients), metastatic nodes with perinodal growth completely invading the adjacent organs and requiring excision of nodes together with these organs [10] . We showed that patients with nodal ex1 or nodal ex2
